Influenza Vaccine Potentially Protective Against Adverse Events Following COVID-19 Infection, Findings Suggest

HealthDay (8/17) reports, “Influenza vaccination has a potential protective effect against adverse events within 120 days of a positive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) diagnosis, according to” researchers who “used a continuou...